Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$444K Sell
10,650
-4,000
-27% -$148K 0.05% 102
2015
Q4
$530K Hold
14,650
0.05% 88
2015
Q3
$467K Hold
14,650
0.04% 94
2015
Q2
$505K Hold
14,650
0.04% 96
2015
Q1
$535K Hold
14,650
0.04% 98
2014
Q4
$620K Hold
14,650
0.04% 92
2014
Q3
$576K Buy
14,650
+3,700
+34% +$148K 0.03% 102
2014
Q2
$444K Hold
10,950
0.02% 114
2014
Q1
$389K Hold
10,950
0.02% 110
2013
Q4
$454K Buy
10,950
+475
+5% +$20.2K 0.03% 112
2013
Q3
$449K Hold
10,475
0.03% 108
2013
Q2
$444K Buy
+10,475
New +$447K 0.03% 97

Other funds holding ITRI

Killen Group's ITRI Position: Q1 2016 in Review

Killen Group reduced its Itron (ITRI) stake by 27% in Q1 2016, selling an estimated $148K and leaving 10,650 shares worth $444K. The position accounts for 0.05% of the portfolio, ranked #102.

Killen Group first reported a position in ITRI in Q2 2013 and has held it in 12 quarters since. The position peaked at $620K in Q4 2014. 193 funds tracked by Wall St. Rank hold ITRI as of Q1 2016.

  • Killen Group held 10,650 shares of Itron worth $444K as of Q1 2016.
  • Killen Group sold 4,000 Itron shares in Q1 2016, an estimated $148K.
  • Itron made up 0.05% of Killen Group's portfolio in Q1 2016, its #102 holding.
  • Killen Group first reported a position in Itron in Q2 2013 and has held it in 12 quarters since.
  • Killen Group's Itron position peaked at $620K in Q4 2014.
  • 193 funds tracked by Wall St. Rank held Itron as of Q1 2016.

Based on Killen Group's 13F filing for Q1 2016, filed 27 Apr 2016.